Study on 68Ga-RGD PET-CT for Keloid Diagnosis and Treatment Evaluation
A prospective study is being conducted to assess the diagnostic value of 68Ga-RGD PET-CT in keloids.
Phase III
Dermatology / Keloids
Status
Active
Signal Score
6.8
Signal assessment
Signal strength
moderate
Confidence level
moderate
Why it matters
The ongoing study on the diagnostic value of 68Ga-RGD PET-CT for keloids could significantly influence treatment protocols in dermatology. Positive outcomes may lead to new therapeutic approaches, impacting market dynamics and clinical practices.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor results and findings from the study to gauge the effectiveness of 68Ga-RGD PET-CT in clinical practice.
Related companies & assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.